{
    "2020-04-23": [
        [
            {
                "time": "2020-04-15",
                "original_text": "Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC",
                "features": {
                    "keywords": [
                        "NMPA",
                        "Sintilimab",
                        "ALIMTA",
                        "NSCLC"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2020-04-16",
                "original_text": "Stocks Give Up Gains After Negative Report on Coronavirus Drug",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Gains",
                        "Negative Report",
                        "Coronavirus Drug"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-04-17",
                "original_text": "Stock market news live updates: Stocks end little changed after report Gilead's virus treatment disappoints in trial",
                "features": {
                    "keywords": [
                        "Stock Market",
                        "Gilead",
                        "Virus Treatment",
                        "Trial"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-04-18",
                "original_text": "Why The Coronavirus Pandemic Isn't Shaking This Red-Hot Pharma Stock",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Pharma Stock"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-19",
                "original_text": "Negative Report on Gilead Sciences’ Coronavirus Drug Hits Stocks",
                "features": {
                    "keywords": [
                        "Negative Report",
                        "Gilead Sciences",
                        "Coronavirus Drug"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-04-20",
                "original_text": "Lilly Shares Reach Record After Drugmaker Moves Fast on Virus",
                "features": {
                    "keywords": [
                        "Lilly Shares",
                        "Record",
                        "Drugmaker",
                        "Virus"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-21",
                "original_text": "Eli Lilly Q1 Earnings Beat, Coronavirus May Mar Profits",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q1 Earnings",
                        "Coronavirus",
                        "Profits"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-22",
                "original_text": "Eli Lilly Smashes Q1 Earnings Forecast as Trulicity Sales Surge; Boosts 2020 Profit Guidance",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q1 Earnings",
                        "Trulicity Sales",
                        "Profit Guidance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-23",
                "original_text": "Eli Lilly lifts 2020 profit forecast; coronavirus fuels stockpiling of its medicines",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Profit Forecast",
                        "Coronavirus",
                        "Stockpiling"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-24",
                "original_text": "Dow futures edge back as investors await report that could show total unemployed in U.S. tops 25 million",
                "features": {
                    "keywords": [
                        "Dow Futures",
                        "Investors",
                        "Unemployed",
                        "U.S."
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}